Home
Technology
Validation Studies
Applications
Pharmacoeconomics
The Company
Scientific Advisory Board
Founders
Investor Relations
Publications
Employment
Contact
Request Information
News

Investor Relations

For more information regarding Hurel Corporation's investor relations,
please contact:

Robert Freedman
CEO

at:

rfreedman@hurelcorp.com     or    310.652.5900

© 2003-2005 Hurel Corporation. All Rights Reservedeerved.
Hurel and Hµrel are registered trademarks.                                       Legal Notice & Privacy Policy